NO962015D0 - Pyron-derivater som protease-inhibitorer og antivirus-midler - Google Patents

Pyron-derivater som protease-inhibitorer og antivirus-midler

Info

Publication number
NO962015D0
NO962015D0 NO962015A NO962015A NO962015D0 NO 962015 D0 NO962015 D0 NO 962015D0 NO 962015 A NO962015 A NO 962015A NO 962015 A NO962015 A NO 962015A NO 962015 D0 NO962015 D0 NO 962015D0
Authority
NO
Norway
Prior art keywords
protease inhibitors
antivirus agents
pyron
derivatives
pyron derivatives
Prior art date
Application number
NO962015A
Other languages
English (en)
Norwegian (no)
Other versions
NO962015L (no
Inventor
John Michael Domagala
Edmund L Ellsworth
Elizabeth Lunney
Daniel Fred Ortwine
Kimberly Suzanne Para
Josyula Venkata Nagendr Prasad
Tomi Sawyer
Bradley Dean Tait
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,768 external-priority patent/US5808062A/en
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of NO962015L publication Critical patent/NO962015L/no
Publication of NO962015D0 publication Critical patent/NO962015D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Vapour Deposition (AREA)
NO962015A 1993-11-19 1996-05-15 Pyron-derivater som protease-inhibitorer og antivirus-midler NO962015D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15502893A 1993-11-19 1993-11-19
US08/319,768 US5808062A (en) 1993-11-19 1994-10-12 Pyrone derivatives as protease inhibitors and antiviral agents
PCT/US1994/012367 WO1995014014A2 (en) 1993-11-19 1994-10-26 Pyrone derivatives as protease inhibitors and antiviral agents

Publications (2)

Publication Number Publication Date
NO962015L NO962015L (no) 1996-05-15
NO962015D0 true NO962015D0 (no) 1996-05-15

Family

ID=26851948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962015A NO962015D0 (no) 1993-11-19 1996-05-15 Pyron-derivater som protease-inhibitorer og antivirus-midler

Country Status (16)

Country Link
EP (1) EP0729466A1 (ja)
JP (1) JPH09505295A (ja)
AU (1) AU682417B2 (ja)
BG (1) BG62770B1 (ja)
CA (1) CA2174124A1 (ja)
CZ (1) CZ134396A3 (ja)
EE (1) EE9600044A (ja)
FI (1) FI962019A7 (ja)
HR (1) HRP940938A2 (ja)
HU (1) HUT74888A (ja)
IL (1) IL111671A0 (ja)
NO (1) NO962015D0 (ja)
PL (1) PL314484A1 (ja)
RU (1) RU2153497C2 (ja)
SK (1) SK63996A3 (ja)
WO (1) WO1995014014A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168895A1 (es) * 1999-03-26 2002-06-16 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
ES2154561B1 (es) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
PE20011333A1 (es) 2000-03-16 2002-01-16 Almirall Prodesfarma Ag Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
ES2844184T3 (es) * 2016-06-14 2021-07-21 Bristol Myers Squibb Co 4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
US10508104B2 (en) * 2016-06-14 2019-12-17 Bristol-Myers Squibb Company 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3724M (fr) * 1963-12-04 1965-12-06 Marcel Perrault Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone.
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
DE4308451A1 (de) * 1992-09-10 1994-04-14 Bayer Ag 3-Aryl-pyron-Derivate
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
JP3372338B2 (ja) * 1994-02-14 2003-02-04 オリンパス光学工業株式会社 測距装置

Also Published As

Publication number Publication date
WO1995014014A3 (en) 1995-06-15
JPH09505295A (ja) 1997-05-27
BG62770B1 (bg) 2000-07-31
CA2174124A1 (en) 1995-05-26
SK63996A3 (en) 1996-11-06
WO1995014014A2 (en) 1995-05-26
HUT74888A (en) 1997-02-28
AU8127694A (en) 1995-06-06
BG100564A (bg) 1996-12-31
NO962015L (no) 1996-05-15
EE9600044A (et) 1996-10-15
FI962019A0 (fi) 1996-05-13
AU682417B2 (en) 1997-10-02
HU9601347D0 (en) 1996-07-29
CZ134396A3 (en) 1996-08-14
RU2153497C2 (ru) 2000-07-27
IL111671A0 (en) 1995-01-24
PL314484A1 (en) 1996-09-16
FI962019L (fi) 1996-05-20
FI962019A7 (fi) 1996-05-20
HRP940938A2 (en) 1997-06-30
EP0729466A1 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
NO942064D0 (no) yminhibitorer
FI962315A0 (fi) Entsyymi-inhibiittorit
DK0922697T3 (da) Substituerede pyrazolylbenzensulfonamider og anvendelse deraf som cyclooxygenase II-inhibitorer
NO961432D0 (no) Benzofiofener og beslektede forbindelser som östrogen-agonister
NO990405D0 (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
NO962322D0 (no) Substituerte N-(indol-2-karbonyl)--alanimamider og derivater som antidiabetiske midler
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20006718D0 (no) Proteaseinhibitorer
DK0722439T3 (da) HIV-proteaseinhibitorer
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
FI20012510L (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
NO974403D0 (no) Reversible proteasehemmere
FI961857A7 (fi) Matriksin metalloproteaasien inhibiittorit
ATE230275T1 (de) Angiogense-inhibitor
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI960482A7 (fi) Matriksin metalloproteaasien inhibiittorit
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
FI962488A7 (fi) HIV:n proteaasin inhibiittoreita
NO954321L (no) 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer
NO962015D0 (no) Pyron-derivater som protease-inhibitorer og antivirus-midler
NO922151D0 (no) Gingerol og gingerdiolderivater som hyperkolesterolemiskeog antiatherosklerotiske midler
DE69431454D1 (de) Amylase Inhibitoren
FI962020L (fi) Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
NO950327D0 (no) Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application